FDA approves AstraZeneca's drug for a rare kidney disease in adults

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved a drug for a rare kidney disease in adults. The approval makes it possible to provide treatment to a group of patients suffering from this rare disease.

AI-written summary of 2 sources; every verified point is backed by a verbatim quote. How Iyan works

• The approval was issued by the US Food and Drug Administration (FDA), and was announced by AstraZeneca.

  «أعلنت AstraZeneca أن هيئة الغذاء والدواء الأمريكية FDA وافقت على دواء لمرض كلوي نادر لدى البالغين.»

  Reuters • investing.com
• The drug is intended for adults with a rare kidney disease, according to reports.

  «وافقت على دواء لمرض كلوي نادر، وفق ما نشره موقع investing.com.»

  Reuters • investing.com

Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms